Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid.

Peña E, Mata M, López-Manzanares L, Kurtis M, Eimil M, Martínez-Castrillo JC, Navas I, Posada IJ, Prieto C, Ruíz-Huete C, Vela L, Venegas B; en nombre del grupo de trastornos del movimiento de la Asociación Madrileña de Neurología.

Neurologia. 2016 Mar 19. pii: S0213-4853(16)00055-4. doi: 10.1016/j.nrl.2016.02.002. [Epub ahead of print] English, Spanish.

2.

The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).

Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, Mas N, Hofeneder D, Brücke T, Bayés A, Wenzel K, Infante J, Zach H, Pirker W, Posada IJ, Álvarez R, Ispierto L, De Fàbregues O, Callén A, Palasí A, Aguilar M, Martí MJ, Valldeoriola F, Salamero M, Poewe W, Tolosa E.

Mov Disord. 2015 Feb;30(2):229-37. doi: 10.1002/mds.26077. Epub 2014 Dec 1.

PMID:
25449044
3.

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

PMID:
25420207
4.

Inter-Rater Agreement in the Clinical Diagnosis of Essential Tremor: Data from the NEDICES-2 Pilot Study.

Sierra-Hidalgo F, Romero JP, Bermejo-Pareja F, Sánchez-Ferro A, Hernández-Gallego J, Posada IJ, Benito-León J, Louis ED.

Tremor Other Hyperkinet Mov (N Y). 2014 Feb 4;4. pii: tre-04-187-4774-3. doi: 10.7916/D8JD4TQ0. eCollection 2014.

5.

Hemifacial spasm, vertebrobasilar dolichoectasia and neurofibromatosis type 1.

de Pablo-Fernández E, Correas-Callero E, Sierra-Hidalgo F, Posada IJ.

J Clin Neurosci. 2012 Jul;19(7):1046-7. doi: 10.1016/j.jocn.2011.05.033. Epub 2012 Apr 3.

PMID:
22480682
6.

Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study.

Cubo E, Benito-León J, Coronell C, Armesto D; ANIMO Study Group.

Neuroepidemiology. 2012;38(1):48-55. doi: 10.1159/000334314. Epub 2012 Jan 6.

7.

Mortality from Parkinson's disease: a population-based prospective study (NEDICES).

Posada IJ, Benito-León J, Louis ED, Trincado R, Villarejo A, Medrano MJ, Bermejo-Pareja F.

Mov Disord. 2011 Dec;26(14):2522-9. doi: 10.1002/mds.23921. Epub 2011 Sep 13.

PMID:
21915906
8.

Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study.

Benito-León J, Cubo E, Coronell C; ANIMO Study Group.

Mov Disord. 2012 Feb;27(2):211-8. doi: 10.1002/mds.23872. Epub 2011 Jul 20.

PMID:
21780179
9.

Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES).

Benito-León J, Louis ED, Posada IJ, Sánchez-Ferro Á, Trincado R, Villarejo A, Mitchell AJ, Bermejo-Pareja F.

J Neurol Sci. 2011 Nov 15;310(1-2):176-82. doi: 10.1016/j.jns.2011.06.054. Epub 2011 Jul 21.

PMID:
21774946
10.

Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.

Villarejo A, Benito-León J, Trincado R, Posada IJ, Puertas-Martín V, Boix R, Medrano MR, Bermejo-Pareja F.

J Alzheimers Dis. 2011;26(3):543-51. doi: 10.3233/JAD-2011-110443.

PMID:
21694455
11.

Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).

Sánchez-Ferro Á, Benito-León J, Mitchell AJ, Louis ED, Posada IJ, Trincado R, Villarejo A, Bermejo-Pareja F.

J Neurol Sci. 2011 Nov 15;310(1-2):211-5. doi: 10.1016/j.jns.2011.05.007. Epub 2011 May 28.

PMID:
21621225
12.

Botulinum toxin-responsive oromandibular dystonia in cerebrotendinous xanthomatosis.

Posada IJ, Ramos A.

Parkinsonism Relat Disord. 2011 Aug;17(7):570-2. doi: 10.1016/j.parkreldis.2011.04.006. Epub 2011 Apr 29. No abstract available.

PMID:
21531161
13.

[Mitochondrial DNA depletion and POLG mutations in a patient with sensory ataxia, dysarthria and ophthalmoplegia].

Posada IJ, Gallardo ME, Domínguez C, Rivera H, Cabello A, Arenas J, Martín MA, Garesse R, Bornstein B.

Med Clin (Barc). 2010 Oct 2;135(10):452-5. doi: 10.1016/j.medcli.2010.03.031. Epub 2010 Jun 23. Spanish.

PMID:
20576279
14.

A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators.

N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335. Erratum in: N Engl J Med. 2011 May 12;364(19):1882.

15.

[Galantamine therapy in dementia associated with CADASIL].

Posada IJ, Ferrero M, Lopez-Valdes E, Goni-Imizcoz M.

Rev Neurol. 2008 Sep 16-30;47(6):299-300. Spanish.

16.

[Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study)].

Gil-Néciga E, Gobartt AL; grupo de investigadores del estudio TRAIN.

Rev Neurol. 2008 Apr 16-30;46(8):461-4. Spanish.

17.

Progressive multifocal leukoencephalopathy in a patient with hepatosplenic T cell lymphoma.

González de la Aleja J, Giménez-Mesa E, Posada IJ, Gonzalo-Martínez JF, Bustelo R, Escudero L.

Eur Neurol. 2006;55(1):44-5. Epub 2006 Feb 9. No abstract available.

18.

[Adult-onset subacute sclerosing panencephalitis: clinicopathological findings].

González de la Aleja J, Posada IJ, Sepúlveda-Sánchez JM, Galán L, Conde-Gallego E, Ricoy-Campo JR.

Rev Neurol. 2005 Jun 16-30;40(12):729-32. Spanish.

19.

[Anticoagulant treatment in hemorrhagic brains infarts due to large sinus venous thrombosis].

Sepúlveda JM, Posada IJ, González de la Aleja J, Ramos A, Bermejo F.

Neurologia. 2004 Dec;19(10):769-73. Review. Spanish.

PMID:
15568176
20.

[Whipple's disease confined to the brain. A clinical case with pathological confirmation at necropsy].

Posada IJ, Ferreiro-Sieiro A, López-Valdés E, Cabello A, Bermejo-Pareja F.

Rev Neurol. 2004 Jan 16-31;38(2):196-8. Review. Spanish. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk